{
    "2018-08-15": [
        [
            {
                "time": "",
                "original_text": "[增持评级]“大医保”动态跟踪系列报告之一：医保局应运而生 系列新政呼之欲出",
                "features": {
                    "keywords": [
                        "医保局",
                        "新政",
                        "大医保"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "333亿资金恐慌逃离 五类股遭主力机构抛",
                "features": {
                    "keywords": [
                        "资金流出",
                        "恐慌",
                        "主力机构"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "招商证券：上调乐普医疗评级至强烈推荐",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "评级上调",
                        "强烈推荐"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：14种抗癌药将迎新一波降价 荐12股",
                "features": {
                    "keywords": [
                        "抗癌药",
                        "降价",
                        "医疗保健"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "业绩延续快速增长 推出员工持股计划强化激励",
                "features": {
                    "keywords": [
                        "业绩增长",
                        "员工持股",
                        "激励"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【财通医药】乐普医疗(300003)：中报略超预期，广布局持续高增长",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "中报",
                        "高增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]乐普医疗(300003)：扣非净利润增速36.67%符合预期 器械药品板块稳定快速增长 未来新品值得期待",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "扣非净利润",
                        "器械药品",
                        "新品"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]乐普医疗(300003)中报点评：H1扣非净利润增长37% 拟发行第一期员工持股计划",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "中报",
                        "员工持股计划"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[强烈推荐评级]乐普医疗(300003)中报点评：业绩符合预期 员工持股增强业绩确定性",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "中报",
                        "员工持股",
                        "业绩确定性"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业日报：国家基本药物制度面临调整",
                "features": {
                    "keywords": [
                        "医药生物",
                        "基本药物制度",
                        "调整"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【医药-崔文亮】乐普医疗：业绩保持快速增长符合预期，公布第一期员工持股计划（草案）",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "业绩增长",
                        "员工持股计划"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "三大数据揭秘外资新动向 QFII二季度增仓21只个股",
                "features": {
                    "keywords": [
                        "外资",
                        "QFII",
                        "增仓"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "乐普医疗:高速增长持续兑现,业绩符合预期",
                "features": {
                    "keywords": [
                        "乐普医疗",
                        "高速增长",
                        "业绩"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}